Eli Lilly’s Mounjaro launch in India ignites wave of weight-loss enquiries

By Rishika Sadam HYDERABAD (Reuters) -The India launch of Eli Lilly’s popular weight-loss drug Mounjaro has triggered a huge wave of patient enquiries about its availability, with some Indian doctors fielding hundreds of calls about the medicine, according to a Reuters survey. The survey of 18 doctors, patients and weight-loss clinic operators follows the U.S….

Read More

OpenAI launches new GPT-4.1 models with improved coding, long context comprehension

(Reuters) – OpenAI on Monday launched its new AI model GPT-4.1, along with smaller versions GPT-4.1 mini and GPT-4.1 nano, touting major improvements in coding, instruction following, and long context comprehension. The new models, available only on OpenAI’s application programming interface (API), outperform the company’s most advanced GPT-4o model across the board, the ChatGPT maker…

Read More

Exclusive-Alphabet, Nvidia invest in OpenAI co-founder Sutskever’s SSI, source says

By Kenrick Cai and Krystal Hu SAN FRANCISCO (Reuters) – Alphabet and Nvidia have joined prominent venture capital investors to back Safe Superintelligence (SSI), a startup co-founded by OpenAI’s former chief scientist Ilya Sutskever that has quickly risen to become one of the most valuable artificial intelligence startups months after its launch, a source familiar with…

Read More